Title |
Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference
|
---|---|
Published in |
Journal of Pharmaceutical Policy and Practice, March 2016
|
DOI | 10.1186/s40545-016-0056-8 |
Pubmed ID | |
Authors |
Sabine Vogler, Nina Zimmermann, Alessandra Ferrario, Veronika J. Wirtz, Kees de Joncheere, Hanne Bak Pedersen, Guillaume Dedet, Valérie Paris, Aukje K. Mantel-Teeuwisse, Zaheer-Ud-Din Babar, on behalf of the Scientific Programme Committee of the 2015 PPRI Conference |
Abstract |
In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The research presented highlighted that commonly used pharmaceutical pricing and reimbursement policies are not sufficiently effective to address current challenges. Conference participants called for fundamental reforms to ensure access to medicines, particularly to new and potentially more effective and/or safe medicines, while safeguarding the financial sustainability of health systems and working towards universal health coverage. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 29% |
India | 1 | 14% |
United States | 1 | 14% |
Ireland | 1 | 14% |
Unknown | 2 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 5 | 71% |
Members of the public | 1 | 14% |
Science communicators (journalists, bloggers, editors) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 37 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 14 | 38% |
Researcher | 5 | 14% |
Student > Ph. D. Student | 4 | 11% |
Student > Postgraduate | 2 | 5% |
Student > Bachelor | 1 | 3% |
Other | 4 | 11% |
Unknown | 7 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 24% |
Medicine and Dentistry | 6 | 16% |
Business, Management and Accounting | 4 | 11% |
Nursing and Health Professions | 3 | 8% |
Economics, Econometrics and Finance | 3 | 8% |
Other | 4 | 11% |
Unknown | 8 | 22% |